|
|
|
Non-required
national studies, e.g., NSSE,
CSEQ, NSoFaS:04. |
|
Yes No |
|
|
|
Studies
primarily for external use, e.g., conference presentations,
scholarly or professional publications. |
|
Yes No |
|
|
|
Other (please
describe): Yes No |
|
|
|
|
3.
|
Does your
institution require the NIH human
subjects training which may be found at http://ohsr.od.nih.gov/extramural/extramural_training.html?
|
|
Yes No |
|
|
|
If no, or
your
IRB requires additional training, please briefly describe the required
human
subjects training or provide the appropriate
URL: |
|
|
|
|
4.
|
Does your
office require researchers to provide
IRB protocol numbers before providing individually identifiable data? |
|
Yes No |
|
|
5.
|
The
additional impact of the Health Insurance
Portability and Accountability Act (HIPAA) has been: |
|
No Impact Positive Negative |
|
|
6.
|
Number of
projects your office submits for IRB
approval annually. |
|
|
|
|
7.
|
Of the
projects your office submits for IRB
approval, what percentage qualify for: |
|
|
|
|
8.
|
Percentage of
the projects
approved as originally submitted. |
|
|
|
|
9.
|
How
frequently does your IRB meet? |
|
Weekly Monthly Quarterly Semi-Annually Annually
Other
(specify): |
|
|
10.
|
For research
done in conjunction with another
organization, does your institution require a copy of the IRB approval
from the
other organization? |
|
Yes No |
|
|
11.
|
Is the IRB
meeting schedule posted so it is
accessible to the entire campus? |
|
Yes No |
|
|
12.
|
Number of
days prior to the scheduled IRB
meeting must you submit the required paperwork for full review. |
|
|
|
|
13.
|
Estimated
number of hours required to complete
required paperwork for a project subject to: |
|
Exempt Review
Expedited Review Full
Review |
|
|
14.
|
How timely is
IRB approval for projects subject
to: |
|
Exempt Review:Excellent Good Fair
Poor Not Applicable |
|
Expedited Review:Excellent Good Fair
Poor Not Applicable |
|
|
|
|
15.
|
Have you
changed any policies or procedures
related to surveys due to IRB requirements? |
|
Yes No |
|
|
16.
|
Does the IRB
or other organization
provide training? |
|
Yes No |
|
|
17.
|
Does the IRB
or other organization
provide pre-submission assistance? |
|
Yes No |
|
|
18.
|
Does the IRB
communicate with you in a timely
and effective manner? |
|
Yes No |
|
|
19.
|
As a
principal investigator, do you understand the
IRB process? |
|
Yes No |
|
|
20.
|
Describe any
positive aspects of the IRB
process. |
|
|
|
|
21.
|
Describe any
negative aspects of the IRB
process. |
|
|
|
|
22.
|
Carnegie
Classification
|
|
|
23.
|
Does your
institution have a medical school? |
|
Yes No |
|
|
24.
|
Name of your
office. |
|
|
|
|
25. |
Organizational
level where your office reports: |
|
Chief Executive, e.g., President or Chancellor
Senior Academic
Officer, e.g., Provost, Vice President, or Vice Chancellor
Other Academic
Officer,
e.g., Associate/Assistant Provost, Academic Vice President/Vice
Chancellor
Senior
Administrative Officer, e.g., Vice President or Vice Chancellor
Other Administrative
Officer, e.g., Associate/Assistant Vice President or Vice
Chancellor
Other
(specify): |
|
|
26.
|
Your title: |
|
Provost, Academic Vice President, or Academic Vice Chancellor
Associate/Assistant
Provost, Vice President, or Vice Chancellor
Administrative Vice
President or Vice
Chancellor
Associate/Assistant
Administrative Vice President or Vice Chancellor
Institutional Research
Director or equivalent
Associate/Assistant
Institutional Research Director or equivalent
Institutional Research
Staff
Other
(specify): |
|
|
27.
|
Please list
additional issues related to IRBs that should be examined.
|
|
|
|
|
28.
|
Please
suggest improvements for this survey. |
|
|
|
|
29.
|
Optional - If
you would
like a copy of the findings, please
provide your email address. This will be separated from your
responses.
|
|
|
|
|
|
|